The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 5, 2012, Pages 805-815

  Shiino, Akihiko ^a   Watanabe, Toshiyuki ^b   Shirakashi, Yoshitomo ^a   Kotani, Emi ^a   Yoshimura, Masahiro ^a   Morikawa, Shigehiro ^a   Inubushi, Toshiro ^a   Akiguchi, Ichiro ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Center for Cerebrovascular Disease   (Japan)

Author keywords

Alzheimer's disease; atherosclerosis; dementia; magnetic resonance spectroscopy; vascular cognitive impairment

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GAIT DISORDER; HEART ARRHYTHMIA; HIPPOCAMPUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN VIVO STUDY; LONG TRACT SIGN; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROLOGIC EXAMINATION; OVERACTIVE BLADDER; PARKINSONISM; PRECUNEAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOBULBAR SIGN; RECEIVER OPERATING CHARACTERISTIC; STROKE; SUBCORTICAL ISCHEMIC VASCULAR DEMENTIA; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACIDS; BRAIN ISCHEMIA; DEMENTIA, VASCULAR; FEMALE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 84862806114     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.9     Document Type: Article

References (44)

1. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H (1998) Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol 95: 78-84 (Pubitemid 28075930)
2. Akiguchi I, Tomimoto H, Wakita H, Kawamoto Y, Matsuo A, Ohnishi K, Watanabe T, Budka H (2004) Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains. Acta Neuropathol 107: 563-70 (Pubitemid 38765399)
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington DC: American Psychiatric Association
4. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38: 95-113 (Pubitemid 47440133)
5. Auer DP, Schirmer T, Heidenreich JO, Herzog J, Putz B, Dichgans M (2001) Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study. Neurology 56: 635-42 (Pubitemid 32209998)
6. Bennett DA, Wilson RS, Gilley DW, Fox JH (1990) Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 53: 961-5 (Pubitemid 20378898)
7. Bernabeu A, Alfaro A, Garcia M, Fernandez E (2009) Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects. Neuroimage 47: 1172-6
8. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Bobinski M, Reisberg B, De Leon MJ, Miller DC (1996) Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 17: 909-19 (Pubitemid 27022745)
9. Bowler JV (2007) Modern concept of vascular cognitive impairment. Br Med Bull 83: 291-305 (Pubitemid 47614262)
10. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15: 289-98 (Pubitemid 24258162)
11. Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O'Brien JT (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132: 195-203
12. Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, Zang FC (2009) Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement Geriatr Cogn Disord 28: 558-66
13. Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG (2002) Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 20: 527-33 (Pubitemid 35304038)
14. Choi CG, Frahm J (1999) Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 41: 204-7 (Pubitemid 29068055)
15. de Graaf RA (ed) (2007) In Vivo NMR Spectroscopy. Principles and Techniques 2nd edn. Chichester, West Sussex: John Wiley & Sons.
16. de la Torre JC (2010) The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis 7: 116-21
17. Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW (2002) Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 58: 1635-41 (Pubitemid 34602894)
18. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-46 (Pubitemid 47058377)
19. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59: 23-30 (Pubitemid 30479402)
20. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-20 (Pubitemid 29424028)
21. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, Inagaki H, Iwasa H, Ura C, Yatomi N, Ishii K, Tokumaru AM, Homma A, Nasreddine Z, Shinkai S (2010) Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 10: 225-32
22. Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004: 169-79 (Pubitemid 19193177)
23. Herminghaus S, Frolich L, Gorriz C, Pilatus U, Dierks T, Wittsack HJ, Lanfermann H, Maurer K, Zanella FE (2003) Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy. Psychiatry Res 123: 183-90 (Pubitemid 36962961)
24. Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (1999) High brain myoinositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry 156: 1879-86
25. Jessen F, Gur O, Block W, Ende G, Frolich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kolsch H, Kornhuber J, Traber F (2009) A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology 72: 1735-40
26. Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, Josephs KA, Boeve BF, Petersen RC, Jack Jr CR (2008) Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 248: 210-20
27. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack Jr CR (2004) 1H MR spectroscopy in common dementias. Neurology 63: 1393-8
28. Kreis R, Ernst T, Ross SIVD (1993) Absolute quantification of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 102: 9-19
29. Kril JJ, Hodges J, Halliday G (2004) Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci Lett 361: 9-12 (Pubitemid 38609203)
30. Kril JJ, Patel S, Harding AJ, Halliday GM (2002) Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 72: 747-51 (Pubitemid 34557018)
31. Lang F (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26: 613-23
32. Launer LJ, Petrovitch H, Ross GW, MarkesberyW, White LR (2008) AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 29: 1587-90
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-44 (Pubitemid 14076461)
34. O'Sullivan M, Ngo E, Viswanathan A, Jouvent E, Gschwendtner A, Saemann PG, Duering M, Pachai C, Bousser MG, Chabriat H, Dichgans M (2009) Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging 30: 890-7
35. Petrovitch H, White LR, Ross GW, Steinhorn SC, Li CY, Masaki KH, Davis DG, Nelson J, Hardman J, Curb JD, Blanchette PL, Launer LJ, Yano K, Markesbery WR (2001) Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 57: 226-34 (Pubitemid 32667355)
36. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-9 (Pubitemid 23360802)
37. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Tan J (1998) In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am 8: 809-22 (Pubitemid 28532518)
38. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust WJ, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW (2003) Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 61: 358-64 (Pubitemid 36975966)
39. Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M (2006) Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 33: 17-26 (Pubitemid 44397587)
40. Shinagawa F, Kobayashi S, Fujita K, Maekawa H (1990) Japanese Wechsler Adult Intelligence Scale-Revised. Tokyo: Nihon Bunka Kagakusha
41. Sugishita M (2001) Japanese Wechsler Memory Scale-Revised. Tokyo: Nihon Bunka Kagakusha
42. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59: 931-45
43. Viswanathan A, Gray F, Bousser MG, Baudrimont M, Chabriat H (2006) Cortical neuronal apoptosis in CADASIL. Stroke 37: 2690-5 (Pubitemid 44922527)
44. Waldman ADB, Rai GS, McConnell JR, Chaudry M, Grant D (2002) Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and subcortical ischemic vascular dementia in older people. Arch Gerontol Geriatr 35: 137-42 (Pubitemid 34603660)